首页> 外国专利> Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing and using tumor necrosis factor superfamily and TNF-like ligand muteins

Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing and using tumor necrosis factor superfamily and TNF-like ligand muteins

机译:肿瘤坏死因子超家族和TNF样配体突变蛋白以及制备和使用肿瘤坏死因子超家族和TNF样配体突变蛋白的方法

摘要

The present invention relates to the substitution of at least one cysteine residue where each TNFSF ligand or TNF-like ligand mutein monomer promotes the formation of disulfide bonds with cysteine residues on adjacent TNFSF or TNF-like ligand mutein monomers. Or a homomultimer of the TNFSF or TNF-like ligand mutein containing an insertion, eg, a homotrimer. The present invention relates to a method for producing such TNFSF and TNF-like ligand muteins, pharmaceutical compositions containing such muteins, and cancer maturins, cancer immunotherapy, treatment of autoimmune and neurological diseases, and organ transplantation or tissue or organ Characterized by methods used to reduce or eliminate the risk of complications and rejection in repair or regeneration. [Selection figure] None
机译:本发明涉及至少一个半胱氨酸残基的取代,其中每个TNFSF配体或TNF样配体突变蛋白单体促进与相邻的TNFSF或TNF样配体突变蛋白单体上的半胱氨酸残基形成二硫键。或包含插入物的TNFSF或TNF样配体突变蛋白的同源多聚体,例如同源三聚体。本发明涉及一种生产此类TNFSF和TNF样配体突变蛋白的方法,含有此类突变蛋白和癌成熟蛋白的药物组合物,癌症免疫疗法,自身免疫和神经疾病的治疗以及器官移植或组织或器官,其特征在于用于减少或消除并发症或修复或再生排斥的风险。 [选择图]无

著录项

  • 公开/公告号JP2017525370A

    专利类型

  • 公开/公告日2017-09-07

    原文格式PDF

  • 申请/专利号JP20170510293

  • 申请日2015-08-20

  • 分类号C12N15/09;C07K14/525;C12P21/02;C07K14/47;C12N1/15;C12N1/19;C12N1/21;C12N5/10;A61K38/16;A61K38/19;A61P37/06;A61P3/10;A61P35;A61P35/02;A61P25;A61P25/18;A61P25/08;A61P21/02;A61P25/16;A61P25/14;A61P31;A61P31/12;A61P1/16;A61P31/18;A61P31/06;A61P31/08;A61P3;A61P27/02;A61P19/08;A61P37/08;A61P3/04;

  • 国家 JP

  • 入库时间 2022-08-21 13:57:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号